Gracell Biotechnologies EPS Diluted (TTM) Analysis

Gracell Biotechnologies Inc (DELISTED) (GRCL:DL)

10.25 0.00 (0.00%) USD | NASDAQ | Feb 22, 16:00

EPS Diluted (TTM) Chart

Historical EPS Diluted (TTM) Data

View and export this data back to 2020. Upgrade now.

Date	Value
September 30, 2023	-1.020
June 30, 2023	-1.282
March 31, 2023	-1.300
December 31, 2022	-1.341
September 30, 2022	-1.364
June 30, 2022	-1.285
March 31, 2022	-1.184

Date	Value
December 31, 2021	-1.069
September 30, 2021	-1.002
June 30, 2021	-0.8604
March 31, 2021	-1.085
December 31, 2020	-1.140
September 30, 2020	-1.293

Earnings per Share Definition

Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.

Read full definition.

EPS Diluted (TTM) Range, Past 5 Years

-1.364

Minimum

Sep 2022

-0.8604

Maximum

Jun 2021

-1.171

Average

-1.184

Median

Mar 2022

EPS Diluted (TTM) Benchmarks